Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

INO Inovio Pharmaceuticals

1.765
+0.040+2.32%
Trading Session 10/03 10:51 ET
High
1.790
Open
1.770
Turnover
2.16M
Low
1.695
Pre Close
1.725
Volume
1.24M
Market Cap
440.19M
P/E(TTM)
Loss
52wk High
7.770
Shares
249.40M
P/E(Static)
Loss
52wk Low
1.380
Float Cap
433.31M
Bid/Ask %
9.40%
Historical High
196.000
Shs Float
245.50M
Volume Ratio
1.15
Historical Low
0.600
Dividend TTM
--
Div Yield TTM
--
P/B
1.48
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.50%
Amplitude
5.51%
Avg Price
1.747
Lot Size
1
Float Cap
433.31M
Bid/Ask %
9.40%
Historical High
196.000
Shs Float
245.50M
Volume Ratio
1.15
Historical Low
0.600
Dividend TTM
--
P/B
1.48
Dividend LFY
--
Turnover Ratio
0.50%
Amplitude
5.51%
Avg Price
1.747
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
CEO: Dr. Jacqueline E. Shea
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...